Norbert Grzasko

Norbert Grzasko

UNVERIFIED PROFILE

Are you Norbert Grzasko?   Register this Author

Register author
Norbert Grzasko

Norbert Grzasko

Publications by authors named "Norbert Grzasko"

Are you Norbert Grzasko?   Register this Author

30Publications

939Reads

28Profile Views

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Leukemia 2019 Sep 9;33(9):2324-2330. Epub 2019 Apr 9.

ProfilExpert, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0452-6DOI Listing
September 2019

F-fluoro-ethyl-tyrosine (F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study.

Contemp Oncol (Pozn) 2019 4;23(1):23-31. Epub 2019 Mar 4.

Department of Haematology, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2019.83342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500394PMC
March 2019

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 Feb 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Apr;374(17):1621-34

From University Hospital Hôtel Dieu, Nantes (P.M., C.T.), the Department of Hematology, Institut Paoli-Calmettes, Marseille (A.-M.S.), and the Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris (L.G.) - all in France; the Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary (T.M.); the Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, and St. John's Cancer Center, Lublin, Poland (N.G.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary (N.J.B.), and the Division of Hematology, Department of Medicine, University of Alberta, Edmonton (I.S.) - both in Canada; the Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden (M.H.); Hematology and Oncology, University Hospital Brno, Brno, Czech Republic (L.P.); the Department of Haematology, Christchurch Hospital, Christchurch (P. Ganly), the Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu (B.W.B.), the Department of Haematology, Middlemore Hospital, Auckland (S.R.J.), and the Department of Haematology, North Shore Hospital, Auckland (D.R.S.) - all in New Zealand; the Department of Hematology, University Hospital Rigshospitalet, Copenhagen (P. Gimsing); Myeloma Unit, Division of Hematology, University of Turin, Turin (A.P.), and Seràgnoli Institute of Haematology, Bologna University School of Medicine, St. Orsola-Malpighi University Hospital, Bologna (M.C.) - both in Italy; the Division of Hematology, Mayo Clinic, Rochester, MN (S.K., F.K.B.); and Dana-Farber Cancer Institute, Boston (J.P.L., P.G.R.), and Millennium Pharmaceuticals, Cambridge (D.T.B., J.L., A.D.B., A.-M.H., H.V.) - both in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1516282DOI Listing
April 2016

Therapy-related peripheral neuropathy in multiple myeloma patients.

Hematol Oncol 2015 Dec 14;33(4):113-9. Epub 2014 Nov 14.

Hemato-oncology and Bone Marrow Transplantation Clinic, SPSK1, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2149DOI Listing
December 2015

Thalidomide can promote erythropoiesis by induction of STAT5 and repression of external pathway of apoptosis resulting in increased expression of GATA-1 transcription factor.

Pharmacol Rep 2015 Dec 29;67(6):1193-200. Epub 2015 May 29.

Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharep.2015.05.011DOI Listing
December 2015

Optimizing the treatment of patients with multiple myeloma and renal impairment.

Clin Lymphoma Myeloma Leuk 2015 Apr 5;15(4):187-98. Epub 2014 Oct 5.

Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.09.012DOI Listing
April 2015

A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization.

Pharmacol Rep 2014 Apr 3;66(2):239-42. Epub 2014 Mar 3.

Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharep.2013.09.005DOI Listing
April 2014

Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma.

Acta Haematol 2008 9;119(3):187-9. Epub 2008 Jun 9.

Department of Hematooncology and Bone Marrow Transplantationt, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000137944DOI Listing
July 2008

[Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].

Authors:
Norbert Grzaśko

Postepy Hig Med Dosw (Online) 2004 ;58:364-71

Katedra i Klinika Hematoonkologii i Transplantacji Szpiku Akademii Medycznej w Lublinie.

View Article

Download full-text PDF

Source
April 2006

Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures.

Eur J Clin Pharmacol 2006 Apr 8;62(4):325-9. Epub 2006 Mar 8.

Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-006-0106-2DOI Listing
April 2006

Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.

Haematologica 2006 Mar;91(3):386-9

Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Staszica 11, 20-080 Lublin, Poland.

View Article

Download full-text PDF

Source
March 2006

[Hemostatic and fibrinolysis markers in the early phase of acute ischaemic stroke].

Pol Arch Med Wewn 2004 Nov;112(5):1303-9

Katedra i Klinika Hematoonkologii i Transplantacji Szpiku AM, Lublinie.

View Article

Download full-text PDF

Source
November 2004